Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Shineco, Inc. Enters into Strategic Cooperation Agreement to Establish the Institute of Chinese Apocynum Industrial Technology Research 2017-06-09 20:00
The Scripps Research Institute and ShangPharma Innovation Announce Translational Research Collaboration 2017-06-08 23:00
ShangPharma Innovation Names New Executives-In-Residence 2017-06-07 23:00
CARsgen Presents Phase I Results of CAR-GPC3 T HCC Trial at ASCO 2017 Annual Meeting 2017-06-05 14:30
ShangPharma Innovation Appoints Mohamad Moghadam-Tabrizi as Senior Vice President of Business Development 2017-05-24 23:00
Hebron Technology Co., Ltd. Wins Bid for a Project at Leading Pharmaceutical Company in Tianjin 2017-05-24 18:30
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended March 31, 2017 2017-05-20 04:30
China Biologic Announces Effectiveness of Registration Statement and Mailing of Definitive Proxy Statement/Prospectus for 2017 Annual Meeting of Stockholders 2017-05-20 04:05
Specialised Therapeutics Asia to License Promising Anti-Cancer Compound Lurbinectedin (PM1183) for South East Asia, Australia and New Zealand 2017-05-18 00:23
Adimmune's Quadrivalent Flu Vaccine Approved by TFDA 2017-05-10 17:46
CPHI to Hold First Quarter 2017 Earnings Conference Call On Friday May 12, 2017 at 8:30 a.m. ET 2017-05-08 18:00
China Biologic Reports Financial Results for the First Quarter of 2017 2017-05-04 04:45
CARsgen Therapeutics Opens CAR T-cell Manufacturing Facility in Shanghai 2017-05-03 19:15
Concord Medical Files 2016 Annual Report on Form 20-F 2017-05-02 17:00
Yisheng Biopharma Starts Enrollment in Phase 1 Immuno-Oncology Clinical Trial of YS-ON-001 in Patients with Advanced Solid Tumors 2017-05-01 20:00
China Biologic Products to Report First Quarter of 2017 Financial Results 2017-04-21 20:00
GNTbm to begin Phase III clinical trial in Taiwan of epigenetic regulator Chidamide for late-stage breast cancer 2017-04-19 21:14
Knee Osteoarthritis: Autologous Conditioned Serum (ACS) Combined with Physiotherapy Led to Significant Improvement in Pain and Function 2016-02-25 09:00
PharmaEssentia Announces Phase II Results of P1101, an Innovative, Mono-pegylated Interferon in Patients with Chronic HCV Genotype 2 Infection 2016-02-23 11:08
PharmaEssentia Announces Phase II Results of P1101, an Innovative, Mono-pegylated Interferon in Patients with Chronic HCV Genotype 1 Infection 2016-02-23 11:04
1 145 146 147 148 149 165